From: The silent struggle: assessing anxiety prevalence in Marrakech’s hypertensive population
Ìý | Bivariate analysis | Multivariate analysis | ||
---|---|---|---|---|
COR (95% CI) | p-value | AOR (95% CI) | p-value | |
Female sex | 2.4 [1.72–3.47] | &±ô³Ù; 0.0001 | 1.5 [0.90–2.68] | 0.10 |
Age in years | Ìý | 0.01 | Ìý | Ìý |
 ≥80 | 0.7 [0.16–3.26] | 0.69 | 1.1 [0.16–8.02] | 0.88 |
 [70–79±Õ | 0.8 [0.19–3.17] | 0.74 | 0.8 [0.14–5.35] | 0.88 |
 [60–69±Õ | 1.2 [0.29–4.56] | 0.82 | 1.2 [0.20–7.28] | 0.81 |
 [50–59±Õ | 1.4 [0.36–5.73] | 0.59 | 1.2 [0.20–7.28] | 0.81 |
 [40–49±Õ | 1.7 [0.41–7.08] | 0.45 | 1.6 [0.26–10.1] | 0.60 |
 [29–39±Õ | 1 | Ìý | Ìý | Ìý |
Urban area | 2.1 [1.50–2.87] | &±ô³Ù; 0.0001 | 1.8 [1.11–2.87] | 0.01 |
Monthly income ($) | Ìý | 0.009 | Ìý | Ìý |
 ≤149 | 6.1 [1.40–26.8] | 0.01 | 2.5 [0.52–12.8] | 0.24 |
 150–199 | 4.3 [0.98–18.5] | 0.05 | 2.9 [0.59–14.2] | 0.18 |
 200–299 | 4.1 [0.94–18.2] | 0.05 | 3.3 [0.68–16.3] | 0.13 |
 300–499 | 5.6 [1.12-28.0] | 0.03 | 3.5 [0.61–20.7] | 0.15 |
 ≥500 | 1 | Ìý | Ìý | Ìý |
Tobacco consumption | 0.5 [0.30–082] | 0.004 | 0.9 [0.39–2.46] | 0.97 |
Alcohol consumption | 0.6 [0.30–1.20] | 0.13 | 1.0 [0.34–2.94] | 0.98 |
Stress | Ìý | &±ô³Ù; 0.0001 | Ìý | Ìý |
 Intense stress | 22.6 [10.9–46.7] | &±ô³Ù; 0.0001 | 12.4 [5.6–27.2] | &±ô³Ù; 0.0001 |
 Moderate stress | 3.8 [1.90–7.78] | 0.0002 | 2.4 [1.12–5.12] | 0.02 |
 Low stress | 1 | Ìý | Ìý | Ìý |
Unsatisfactory physical activity | 1.7 [1.26–2.29] | 0.0003 | 1.1 [0.79–1.79] | 0.38 |
Sedentarity | 1.2 [0.99–1.70] | 0.05 | 1.0 [0.34–2.94] | 0.98 |
Not consuming five fruits and vegetables a day | 1.5 [1.20–2.03] | 0.0007 | 1.4 [1.01–1.97] | 0.04 |
Lack of monitoring hypertension | 1.4 [1.04–2.07] | 0.02 | 1.2 [0.81–1.89] | 0.31 |
Lack of social support | 2.9 [2.26–3.88] | &±ô³Ù; 0.0001 | 1.6 [1.17–2.35] | 0.004 |
Presence of comorbidity | 1.3 [1.05–1.76] | 0.01 | 0.8 [0.37–1.72] | 0.57 |
Presence of diabetes | 1.3 [1.04–1.75] | 0.02 | 1.3 [0.62–2.85] | 0.45 |
Duration of hypertension more than five years | 1.3 [1.01–1.70] | 0.03 | 0.9 [0.71–1.36] | 0.95 |
Family history of hypertension | 2.4 [1.87–3.25] | &±ô³Ù; 0.0001 | 2.2 [1.58–3.13] | &±ô³Ù; 0.0001 |
Lack of autonomy | 1.8 [1.18–2.98] | 0.008 | 1.4 [0.66–2.98] | 0.37 |
Pain and physical discomfort | 2.2 [1.74-3.00] | &±ô³Ù; 0.0001 | 1.8 [1.41–2.48] | &±ô³Ù; 0.0001 |
Reduced mobility | 2.3 [1.60–3.40] | &±ô³Ù; 0.0001 | 1.4 [0.79–2.77] | 0.21 |
Overweigh and obesity | 1.6 [1.16–2.31] | 0.003 | 1.0 [0.65–1.57] | 0.95 |
Unsatisfactory patient relationship with the healthcare system | 2.4 [1.62–3.59] | &±ô³Ù; 0.0001 | 1.2 [0.72–2.25] | 0.39 |
Feel the doctor’s willingness to understand the patient’s hypertension concerns | 1.8 [1.37–2.31] | &±ô³Ù; 0.0001 | 1.1 [0.81–1.68] | 0.40 |
Availability of the drug | 2.4 [1.86–3.26] | &±ô³Ù; 0.0001 | 1.2 [0.82-2.00] | 0.26 |
Non-purchase of a drug if it is out of stock | 3.0 [2.27–4.08] | &±ô³Ù; 0.0001 | 1.8 [1.27–2.76] | 0.001 |
Thinking you have a lot of drugs to take | 2.5 [1.36–4.86] | 0.003 | 1.4 [0.64–3.25] | 0.37 |
Adverse drug effects | 1.5 [1.17–2.08] | 0.002 | 1.1 [0.76–1.63] | 0.56 |